Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-10DNA144Shetty Reshma P. plan to sell securities of Ginkgo Bioworks Holdings, Inc. under Form 144MEDIUM
Shetty Reshma P. filed Form 144 to notify SEC of plan to sell 124727 units of Ginkgo Bioworks Holdings, Inc. securities around 2026-04-10, with aggregate market value of $802,530.94. The total outstanding units is 49941878.0. The amount planned to be sold represents 0.25% of total outstanding units; Recent transactions...
Small CapBiotechnology
2026-04-10MLTX144Jorge Pedro Santos Radeck D Silva plan to sell securities of MoonLake Immunotherapeutics Inc. under Form 144MEDIUM
Jorge Pedro Santos Radeck D Silva filed Form 144 to notify SEC of plan to sell 150000 units of MoonLake Immunotherapeutics Inc. securities around 2026-04-10, with aggregate market value of $2,787,000.00. The total outstanding units is 71727875.0. The amount planned to be sold represents 0.21% of total outstanding units...
Small CapBiotechnology
2026-04-10RAPP144KRISHNASWAMY YELESWARAM plan to sell securities of Rapport Therapeutics, Inc. under Form 144MEDIUM
KRISHNASWAMY YELESWARAM filed Form 144 to notify SEC of plan to sell 500 units of Rapport Therapeutics, Inc. securities around 2026-04-10, with aggregate market value of $17,110.00. The total outstanding units is 47792943.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions ...
Small CapBiotechnology